PERSONAL INFORMATION

Nationality: Syrian

Date of birth: 01-11-1986

EMPLOYMENT HISTORY

2016–2018

Research Scientist | Rohto Pharmaceutics, Kyoto, Japan

A research position in the field of ophthalmic pharmacology and ophthalmic drug

delivery

2014–2015

Teacher Assistant| Sagano High School, Kyoto, Japan

An English Super Science program intended for improving the scientific

communication among students

EDUCATION

2013–2016

Kyoto University | Graduate School of Graduate School | Kyoto, Japan

PhD: Pharmaceutical Sciences

2011–2013

Kyoto University | Graduate School of Graduate School | Kyoto, Japan

MSc: Master in Pharmaceutical Sciences

2004–2009

Damascus University | Damascus, Syria

BSc: Bachelor Degree in Pharmacy and Pharmaceutical Chemistry

LANGUAGES

Kurdish (Native level) Arabic (Native level)

English (Fluent level) Japanese (Upper intermidiate level)

Hobbies

Music (violin), Basketball, and Painting

Publications

PhD Thesis

Rodi Abdalkader. Development of novel phospholipids-based ultrasound contrast

agents intended for drug delivery and cancer theranostics. Doctoral Thesis.

Kyoto University, 2016.

Peer review Journal

• Rodi Abdalkader, Shigeru Kawakami, Johan Unga, Ryo Suzuki, Kazuo Maruyama,

Fumiyoshi Yamashita, and Mitsuru Hashida. Evaluation of the potential of

doxorubicin loaded microbubbles as a theranostic modality using a

murine tumor model (2015). Acta Biomaterialia 19, 112–118.

• Rodi Abdalkader, Shigeru Kawakami, Johan Unga, Yuriko Higuchi, Ryo Suzuki,

Kazuo Maruyama, Fumiyoshi Yamashita & Mitsuru Hashida. The development of

mechanically formed stable nanobubbles intended for sonoporation-mediated

gene transfection (2017). Drug Delivery, 24:1, 320-327

Book Chapters

• Rodi Abdalkader and Mitsuru Hashida. Focused ultrasound ablation

enhancement of specific antitumor immunity (Book title: Image-guided Focused

Ultrasound Therapy: Physics and Clinical Applications, by CRC press Taylor &

Francis group). CRC Press LLC, 2018. ISBN 149871135

Conferences and academic meetings

• Ultrasound triggered doxorubicin loaded microbubbles for effective therapeutic

outcomes in melanoma. Presentation: 72nd Annual meeting of the Japanese

Cancer Association. Yokohama, October 3-5 (2013).

• Theranostic doxorubicin loaded microbubbles as a novel approach in

cancer. Poster: UK-Japan workshop on inorganic framework material. Kyoto,

October 10-11 (2013).

• Ultrasound triggered doxorubicin loaded microbubbles as a novel approach in

cancer. Presentation: 29th Annual meeting of Japanese Academy of

Pharmaceutical Sciences and Technology. Saitama, May 20-22 (2014).

• Ultrasound triggered doxorubicin loaded microbubbles: a novel strategy toward

more effective therapeutic outcomes in cancer. Poster: FIP congress in PSWC.

Melbourne (Australia). April 13-16 (2014).

• Phospholipids-based doxorubicin loaded microbubbles as a

novel tumour theranostic agent. Presentation: The 8th Seoul-Kyoto-Osaka joint

symposium on pharmaceutical sciences for young scientists. Osaka, June 10-11

(2014).

• The formation of doxorubicin loaded microbubbles and their role

in tumour theranostics. Poster: iCeMS International Symposium. Hierarchical

Dynamics in Soft Material and Biological matter. Kyoto, Sept. 23-26 (2015).

• The Development of phase shift acoustic nanodroplets (PSANDs) and their

potential use in ultrasound Theranostics. Poster: The 12th congress of the Asian

Federation of Societies for Ultrasound in Medicine and Biology. Kyoto, May 27-

29 (2016).

• The formulation and evaluation of nano-sized bubbles for sustainable gene

expression in mice limb muscles. Poster: The 1st Workshop for Japan-Korea

Young Scientists on Pharmaceutics. Kyoto, June 24-25 (2016).

• The effect of pluronic F127 on enhancing retinol palmitate delivery in human

corneal epithelial cells. E-Poster: World Ophthalmology Congress of the

International Council of Ophthalmology. Barcelona, Spain, June 16–19 (2018).

Funds and awards

• The Japanese Ministry of Education, Culture, Sports, Science, and Technology

(MEXT)

• Global Education Seminar Award from the Academy of Pharmaceutical

Sciences and Technology, Japan